Search research articles
Contact Us
Filters
Showing results (291-300 of 550) with videos related to
Page
of 55
Sort By:
Chemotherapy
|
January 1, 1986
Enhancement of NK-cell activity in normal and tumor-bearing mice after administration of aclacinomycin
C E Andrade Mena, S Orbach-Arbouys, G Mathé
Nature
|
July 11, 1970
Powerful new inhibitor of murine leukaemia and sarcoma viruses
J C Chermann, M Raynaud, C Jasmin, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]
|
November 1, 1978
Non-H-2 antigens can induce high GVH mortality in adult recipients of normal cells
O Halle-Pannenko, L L Pritchard, R Motta, et al.
Israel Journal of Medical Sciences
|
April 1, 1976
Monitoring of nonspecific cell-mediated immunity in cancer patients. I. Frequent dissociation between the responses of skin tests to recall antigens and in vitro lymphocyte transformation
M C Simmler, G Rameau, M J Chou, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1995
Lysosomal exocytosis induced by hyperthermia: a new model of cancer cell death. II. Effect on peritoneal macrophages
P Pontiggia, S Barni, G Mathé, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1996
Will killing the last HIV1 particle cure AIDS patients? II: Second Part. Decrease of viral load and of T-suppressor cells, and increase of the cytotoxic cells, without effect on CD4, after the use of 10 virostatics applied in 3 or 4 drug combinations of different sequences. The time for CD4 immunotherapy?
G Mathé, U Colasanté, C Morette, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
July 12, 2002
Polyphenols: do they play a role in the prevention of human pathologies?
H Tapiero, K D Tew, G Nguyen Ba, et al.
Israel Journal of Medical Sciences
|
April 1, 1976
Methanol extraction residue fraction of tubercle bacilli (MER) and other mycobacterial extracts as systemic immunity adjuvants in cancer immunotherapy
G Mathé, I J Hiu, O Halle-Pannenko, et al.
Johns Hopkins Medical Journal. Supplement
|
January 1, 1974
The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer
G Mathé, O Halle-Pannenko, C Bourut, et al.
La Nouvelle Presse Medicale
|
July 2, 1977
[Does blastic crisis as revealed in chronic myeloid leukemia simulate either acute primary leukemia or acute primary leukemia with Philadelphia chromosome?]
J L Misset, A M Venuat, L Nevarez, et al.
Page
of 55
Search research articles
Search
Showing results (291-300 of 550) with videos related to
Sort By:
Page
of 55
Chemotherapy
|
January 1, 1986
Enhancement of NK-cell activity in normal and tumor-bearing mice after administration of aclacinomycin
C E Andrade Mena, S Orbach-Arbouys, G Mathé
Nature
|
July 11, 1970
Powerful new inhibitor of murine leukaemia and sarcoma viruses
J C Chermann, M Raynaud, C Jasmin, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]
|
November 1, 1978
Non-H-2 antigens can induce high GVH mortality in adult recipients of normal cells
O Halle-Pannenko, L L Pritchard, R Motta, et al.
Israel Journal of Medical Sciences
|
April 1, 1976
Monitoring of nonspecific cell-mediated immunity in cancer patients. I. Frequent dissociation between the responses of skin tests to recall antigens and in vitro lymphocyte transformation
M C Simmler, G Rameau, M J Chou, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1995
Lysosomal exocytosis induced by hyperthermia: a new model of cancer cell death. II. Effect on peritoneal macrophages
P Pontiggia, S Barni, G Mathé, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
January 1, 1996
Will killing the last HIV1 particle cure AIDS patients? II: Second Part. Decrease of viral load and of T-suppressor cells, and increase of the cytotoxic cells, without effect on CD4, after the use of 10 virostatics applied in 3 or 4 drug combinations of different sequences. The time for CD4 immunotherapy?
G Mathé, U Colasanté, C Morette, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
July 12, 2002
Polyphenols: do they play a role in the prevention of human pathologies?
H Tapiero, K D Tew, G Nguyen Ba, et al.
Israel Journal of Medical Sciences
|
April 1, 1976
Methanol extraction residue fraction of tubercle bacilli (MER) and other mycobacterial extracts as systemic immunity adjuvants in cancer immunotherapy
G Mathé, I J Hiu, O Halle-Pannenko, et al.
Johns Hopkins Medical Journal. Supplement
|
January 1, 1974
The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer
G Mathé, O Halle-Pannenko, C Bourut, et al.
La Nouvelle Presse Medicale
|
July 2, 1977
[Does blastic crisis as revealed in chronic myeloid leukemia simulate either acute primary leukemia or acute primary leukemia with Philadelphia chromosome?]
J L Misset, A M Venuat, L Nevarez, et al.
Page
of 55